Ventyx Biosciences, Inc. ( VTYX )

Derivative

Stock Option (Right to Buy)

40,000

-^{footnote F5}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,000

-^{footnote F5}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

15,937

-^{footnote F6}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

21,825

-^{footnote F6}

Mar 4, 2026

Derivative

Common Stock

3,337,495

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

33,000

-^{footnote F5}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger… Full note on SEC EDGAR
Footnote F5 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted… Full note on SEC EDGAR
Footnote F6 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

40,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

119,120

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

21,825

-^{footnote F3}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

15,937

-^{footnote F3}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

33,000

-^{footnote F2}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal to $14.00 (without interest) per share (the "Per Share Price") and, pursuant to the terms of the… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Matthew Richard Moore - Officer

Derivative

Stock Option (Right to Buy)

320,000

-^{footnote F2}

Mar 4, 2026

Matthew Richard Moore - Officer

Derivative

Stock Option (Right to Buy)

145,000

-^{footnote F2}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal to $14.00 (without interest) per share (the "Per Share Price") and, pursuant to the terms of the… Full note on SEC EDGAR

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

15,937

-^{footnote F3}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,427

-^{footnote F3}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

33,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

40,000

-^{footnote F2}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal to $14.00 (without interest) per share (the "Per Share Price") and, pursuant to the terms of the… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,427

-^{footnote F3}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

33,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

40,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

20,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

15,937

-^{footnote F3}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal to $14.00 (without interest) per share (the "Per Share Price") and, pursuant to the terms of the… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

80,000

-^{footnote F4}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

662,369

-^{footnote F4}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

277,941

-^{footnote F5}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

21,825

-^{footnote F5}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

15,937

-^{footnote F5}

Mar 4, 2026

Derivative

Common Stock

130,000

-^{footnote F2}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

33,000

-^{footnote F4}

Mar 4, 2026

Derivative

Stock Option (Right to Buy)

40,000

-^{footnote F4}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger… Full note on SEC EDGAR
Footnote F4 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted… Full note on SEC EDGAR
Footnote F5 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

415,104

-^{footnote F4}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

125,000

-^{footnote F4}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

181,250

-^{footnote F4}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

192,778

-^{footnote F4}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

145,000

-^{footnote F5}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

139,722

-^{footnote F5}

Mar 4, 2026

John Nuss - Officer

Derivative

Stock Option (right to buy)

108,750

-^{footnote F5}

Mar 4, 2026

John Nuss - Officer

Derivative

Common Stock

489,481

-^{footnote F2}

Mar 4, 2026

John Nuss - Officer

Derivative

Restricted Stock Units

9,063

-^{footnote F3}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding restricted stock unit ("RSU") that was unvested was cancelled and converted solely into the right to receive a cash award (without interest) equal to (i) the total number of shares of common stock subject to such unvested RSU award… Full note on SEC EDGAR
Footnote F4 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted… Full note on SEC EDGAR
Footnote F5 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

700,000

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

155,000

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

473,750

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

370,000

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

335,286

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

7,972

-^{footnote F4}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

284,250

-^{footnote F5}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Stock Option (Right to Buy)

466,672

-^{footnote F5}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Common Stock

2,372,863

-^{footnote F2}

Mar 4, 2026

Raju Mohan - Officer

Derivative

Restricted Stock Units

23,688

-^{footnote F3}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, each outstanding restricted stock unit ("RSU") that was unvested was cancelled and converted solely into the right to receive a cash award (without interest) equal to (i) the total number of shares of common stock subject to such unvested RSU award… Full note on SEC EDGAR
Footnote F4 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted… Full note on SEC EDGAR
Footnote F5 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock was fully vested and had an exercise price per share that was greater than the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically… Full note on SEC EDGAR

Mar 4, 2026

Mark S. Forman - Officer

Derivative

Stock Option (Right to Buy)

350,000

-^{footnote F3}

Mar 4, 2026

Mark S. Forman - Officer

Derivative

Common Stock

6,000

-^{footnote F2}

Mar 4, 2026

Mark S. Forman - Officer

Derivative

Stock Option (Right to Buy)

85,000

-^{footnote F3}

Footnote F2 (price): At the effective time of the Merger (the "Effective Time"), these shares were automatically converted solely into the right to receive cash in an amount equal to $14.00 (without interest) per share (the "Per Share Price"), subject to the terms and conditions of the Merger… Full note on SEC EDGAR
Footnote F3 (price): At the Effective Time, this option to purchase shares of the Issuer's common stock had an exercise price per share that was less than or equal the Per Share Price and, pursuant to the terms of the Merger Agreement, at the Effective Time, was automatically cancelled and converted… Full note on SEC EDGAR

Feb 27, 2026

Other

Common Stock

694,718

$0.00

Dec 17, 2025

Raju Mohan - Officer

Option exercise

Common Stock

116,668

$0.00^{footnote F1}

Dec 18, 2025

Raju Mohan - Officer

Open-market sale

Common Stock

47,345

$7.72^{footnote F3}

$365K

Dec 17, 2025

Raju Mohan - Officer

Option exercise

Restricted Stock Units

116,668

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
Footnote F3 (price): Represents the weighted average share price of an aggregate total of 47,345 shares sold in the price range of $7.595 to $7.85. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information… Full note on SEC EDGAR

Dec 17, 2025

John Nuss - Officer

Option exercise

Common Stock

34,930

$0.00^{footnote F1}

Dec 18, 2025

John Nuss - Officer

Open-market sale

Common Stock

12,675

$7.72^{footnote F3}

$98K

Dec 17, 2025

John Nuss - Officer

Option exercise

Restricted Stock Units

34,930

$0.00

Footnote F1 (price): Each restricted stock unit ("RSU") represents a contingent right to receive one share of Ventyx Biosciences, Inc. common stock.
Footnote F3 (price): Represents the weighted average share price of an aggregate total of 12,675 shares sold in the price range of $7.595 to $7.85. The reporting owner undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information… Full note on SEC EDGAR

Nov 17, 2025

Mark S. Forman - Officer

Grant or award

Common Stock

3,000

$1.03^{footnote F3}

$3K

Footnote F3 (price): In accordance with the 2021 ESPP, these shares were purchased based on 85% of the closing price on May 15, 2025.

Nov 17, 2025

Roy Gonzales - Officer

Grant or award

Common Stock

1,767

$1.03^{footnote F3}

$2K

Footnote F3 (price): In accordance with the 2021 ESPP, these shares were purchased based on 85% of the closing price on May 15, 2025.

Dec 27, 2024

John Nuss - Officer

Open-market sale

Common Stock

21,119

$2.36

$50K

Dec 23, 2024